Marquette Asset Management’s Gilead Sciences GILD Stock Holding History

Marquette Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27K	Sell	214 -11	-5%	-$1.45K	﹤0.01%	207
2026 Q1	$31.4K	Buy	225 +49	+28%	+$6.86K	﹤0.01%	130
2025 Q4	$21.6K	Buy	176 +40	+29%	+$4.86K	﹤0.01%	149
2025 Q3	$15.1K	Buy	+136	New	+$15.5K	﹤0.01%	175
2020 Q1	–	Sell	-917	Closed	-$60K	–	261
2019 Q4	$60K	Hold	917	–	–	0.02%	129
2019 Q3	$58K	Hold	917	–	–	0.02%	140
2019 Q2	$62K	Hold	917	–	–	0.02%	136
2019 Q1	$60K	Buy	+917	New	+$60.9K	0.02%	142

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Marquette Asset Management's GILD Position: Q2 2026 in Review

Marquette Asset Management reduced its Gilead Sciences (GILD) stake by 4.9% in Q2 2026, selling an estimated $1.45K and leaving 214 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #207.

Marquette Asset Management first reported a position in GILD in Q1 2019 and has held it in 8 quarters since. The position peaked at $62K in Q2 2019. 836 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Marquette Asset Management held 214 shares of Gilead Sciences worth $27K as of Q2 2026.
Marquette Asset Management sold 11 Gilead Sciences shares in Q2 2026, an estimated $1.45K.
Gilead Sciences made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #207 holding.
Marquette Asset Management first reported a position in Gilead Sciences in Q1 2019 and has held it in 8 quarters since.
Marquette Asset Management's Gilead Sciences position peaked at $62K in Q2 2019.
836 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.